AB AllianceBernstein | Reiterated by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.90
+0.4% | $38.00 | Buy | |
ACN Accenture | Target Lowered by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $339.64
+0.1% | $376.00 ➝ $370.00 | Overweight ➝ Overweight | |
AHR American Healthcare REIT | Target Raised by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.20
+0.7% | $27.00 ➝ $31.00 | Buy ➝ Buy | |
AIOT Powerfleet | Reiterated by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.91
+2.9% | $10.00 ➝ $10.00 | Outperform ➝ Outperform | |
AIR AAR | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.99
-4.5% | $83.00 ➝ $83.00 | Buy ➝ Buy | |
AIR AAR | Reiterated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.99
-4.5% | $85.00 ➝ $85.00 | Outperform ➝ Outperform | |
Sell NVDA Now? (Ad) Guess who's selling NVDA next
The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%. Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). |
AMWL American Well | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.75
+5.9% | | Hold | |
ANET Arista Networks | Target Raised by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $385.15
-0.1% | $390.00 ➝ $430.00 | Buy ➝ Buy | |
APLS Apellis Pharmaceuticals | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.75
-6.0% | $47.00 ➝ $43.00 | Equal Weight ➝ Equal Weight | |
ASMB Assembly Biosciences | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.15
-6.8% | | Neutral | |
AX Axos Financial | Target Lowered by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.32
-2.3% | $80.00 ➝ $75.00 | Neutral ➝ Neutral | |
AYI Acuity Brands | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. O'dea
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $272.46
+0.3% | $260.00 ➝ $289.00 | Equal Weight ➝ Equal Weight | |
BA Boeing | Target Lowered by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $155.87
-0.3% | $232.00 ➝ $202.00 | Buy ➝ Buy | |
BANC Banc of California | Upgraded by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.03
+1.3% | $14.00 ➝ $18.00 | Neutral ➝ Outperform | |
BDTX Black Diamond Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.58
+1.8% | $11.00 ➝ $11.00 | Buy ➝ Buy | |
BHVN Biohaven | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.04
-2.0% | $59.00 ➝ $59.00 | Buy ➝ Buy | |
BHVN Biohaven | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.04
-2.0% | $59.00 ➝ $68.00 | Outperform ➝ Outperform | |
BHVN Biohaven | Reiterated by | Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.04
-2.0% | | Overweight | |
BHVN Biohaven | Target Raised by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.04
-2.0% | $52.00 ➝ $62.00 | Buy ➝ Buy | |
BHVN Biohaven | Target Raised by | Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating | W. Pickering
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $45.04
-2.0% | $55.00 ➝ $66.00 | Outperform ➝ Outperform | |
BIDU Baidu | Downgraded by | HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.81
+7.4% | $100.00 | Buy ➝ Hold | |
BIIB Biogen | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $194.12
-0.9% | $285.00 ➝ $285.00 | Buy ➝ Buy | |
BIRK Birkenstock | Reiterated by | Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Telsey
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $50.17
+2.0% | $70.00 ➝ $70.00 | Outperform ➝ Outperform | |
BKU BankUnited | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.31
-0.2% | $39.00 ➝ $40.00 | Neutral ➝ Neutral | |
BNTX BioNTech | Upgraded by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $118.47
+4.8% | $93.00 ➝ $145.00 | Equal Weight ➝ Overweight | |
BP BP | Downgraded by | Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.83
-0.1% | | Buy ➝ Neutral | |
BRO Brown & Brown | Initiated by | Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $103.36
+1.1% | $120.00 | Buy | |
BRZE Braze | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.64
-5.7% | $70.00 ➝ $70.00 | Buy ➝ Buy | |
BRZE Braze | Target Lowered by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.64
-5.7% | $52.00 ➝ $45.00 | Buy ➝ Buy | |
BRZE Braze | Target Lowered by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.64
-5.7% | $60.00 ➝ $51.00 | Outperform ➝ Outperform | |
BRZE Braze | Reiterated by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.64
-5.7% | $75.00 ➝ $75.00 | Buy ➝ Buy | |
BRZE Braze | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.64
-5.7% | $68.00 ➝ $68.00 | Market Outperform ➝ Market Outperform | |
BRZE Braze | Target Lowered by | DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.64
-5.7% | $65.00 ➝ $55.00 | Buy ➝ Buy | |
BTG B2Gold | Target Raised by | CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.31
+2.2% | $3.30 ➝ $3.60 | Neutral ➝ Neutral | |
CAPR Capricor Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.10
+52.4% | $40.00 ➝ $40.00 | Buy ➝ Buy | |
CART Maplebear | Target Lowered by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.08
-0.3% | $45.00 ➝ $41.00 | Equal Weight ➝ Equal Weight | |
CART Maplebear | Initiated by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.08
-0.3% | | Market Perform | |
CART Maplebear | Target Raised by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.08
-0.3% | $41.00 ➝ $45.00 | Neutral ➝ Neutral | |
CAVA CAVA Group | Target Raised by | TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $127.45
-0.6% | $115.00 ➝ $130.00 | Buy ➝ Buy | |
CBUS Cibus | Target Lowered by | Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Venezia
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.83
+7.6% | $25.00 ➝ $23.50 | Buy ➝ Buy | |
We recommended Nvidia in 2016, now we’re recommending this… (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
CCK Crown | Reiterated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.72
+0.3% | $105.00 ➝ $105.00 | Outperform ➝ Outperform | |
CELH Celsius | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.63
-3.6% | $50.00 ➝ $47.00 | Overweight ➝ Overweight | |
CF CF Industries | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.90
+2.0% | $88.00 ➝ $92.00 | Overweight ➝ Overweight | |
CFLT Confluent | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.81
+0.6% | $40.00 ➝ $40.00 | Market Outperform ➝ Market Outperform | |
CFR Cullen/Frost Bankers | Target Lowered by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.50
0.0% | $124.00 ➝ $123.00 | Neutral ➝ Neutral | |
CHD Church & Dwight | Initiated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $103.14
-0.4% | $120.00 | Overweight | |
CHKP Check Point Software Technologies | Target Raised by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $195.29
-0.1% | $210.00 ➝ $225.00 | Buy ➝ Buy | |
CIFR Cipher Mining | Initiated by | Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.44
+15.1% | $6.00 | Outperform | |
CL Colgate-Palmolive | Initiated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $103.79
+0.5% | $121.00 | Overweight | |
CLFD Clearfield | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.46
+1.8% | $50.00 ➝ $50.00 | Buy ➝ Buy | |
CMA Comerica | Upgraded by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.46
+0.4% | $52.00 ➝ $75.00 | Neutral ➝ Outperform | |
COGT Cogent Biosciences | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.94
+2.7% | $13.00 ➝ $15.00 | Buy ➝ Buy | |
COLB Columbia Banking System | Upgraded by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.08
+1.3% | $28.00 ➝ $31.00 | Neutral ➝ Outperform | |
COMP Compass | Target Raised by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.59
+6.3% | $6.00 ➝ $8.00 | Outperform ➝ Outperform | |
COST Costco Wholesale | Downgraded by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $901.54
-1.7% | $873.00 ➝ $873.00 | Buy ➝ Hold | |
CRGY Crescent Energy | Reiterated by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.68
+2.2% | $17.00 | Outperform | |
CRM Salesforce | Upgraded by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $270.44
+2.4% | $268.00 ➝ $325.00 | Neutral ➝ Overweight | |
CRWD CrowdStrike | Target Raised by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $288.54
-1.6% | $315.00 ➝ $345.00 | Buy ➝ Buy | |
CRWD CrowdStrike | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $288.54
-1.6% | $400.00 ➝ $400.00 | Market Outperform ➝ Market Outperform | |
CTLT Catalent | Reiterated by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.14
+0.7% | $63.50 ➝ $63.50 | Outperform ➝ Neutral | |
CTVA Corteva | Reiterated by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.85
-0.3% | $65.00 ➝ $65.00 | Overweight ➝ Overweight | |
CUBI Customers Bancorp | Downgraded by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.83
-2.5% | $79.00 ➝ $53.00 | Outperform ➝ Neutral | |
CVBF CVB Financial | Target Lowered by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.84
-1.7% | $21.00 ➝ $20.00 | Neutral ➝ Neutral | |
CYBR CyberArk Software | Target Raised by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $284.51
+0.1% | $315.00 ➝ $330.00 | Buy ➝ Buy | |
DASH DoorDash | Initiated by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $141.68
+1.6% | $155.00 | Outperform | |
DAY Dayforce | Initiated by | KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.41
+2.0% | $70.00 | Overweight | |
DBVT DBV Technologies | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.75
+7.2% | $5.00 ➝ $5.00 | Market Outperform ➝ Market Outperform | |
DOYU DouYu International | Downgraded by | HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.50
+2.3% | | Hold ➝ Reduce | |
DRS Leonardo DRS | Downgraded by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.16
-5.0% | $26.00 ➝ $30.00 | Buy ➝ Neutral | |
EBAY eBay | Target Raised by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.44
+3.1% | $57.00 ➝ $65.00 | Neutral ➝ Neutral | |
EC Ecopetrol | Target Lowered by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.33
+0.8% | $11.00 ➝ $9.50 | Neutral ➝ Neutral | |
EH EHang | Initiated by | China Renaissance
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.24
+12.5% | | Buy | |
EL Estée Lauder Companies | Reiterated by | DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.98
+6.1% | $130.00 ➝ $130.00 | Buy ➝ Buy | |
ENGN enGene | Reiterated by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.20
-3.3% | $30.00 ➝ $30.00 | Outperform ➝ Outperform | |
EPR EPR Properties | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.58
+0.4% | | Market Perform | |
EQIX Equinix | Reiterated by | Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $887.58
+0.6% | | Buy ➝ Hold | |
EQR Equity Residential | Downgraded by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.28
-2.8% | $78.00 ➝ $82.00 | Buy ➝ Neutral | |
ESS Essex Property Trust | Downgraded by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $300.23
-3.0% | $307.00 ➝ $321.00 | Buy ➝ Neutral | |
ETSY Etsy | Reiterated by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.02
+0.3% | $76.00 ➝ $76.00 | Buy ➝ Buy | |
FBLG FibroBiologics | Initiated by | Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.92
+5.8% | $12.00 | Buy | |
FCNCA First Citizens BancShares | Downgraded by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,856.96
-5.1% | $2,450.00 ➝ $2,150.00 | Outperform ➝ Neutral | |
FFIV F5 | Target Raised by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $223.60
+1.5% | $185.00 ➝ $212.00 | Neutral ➝ Neutral | |
FHN First Horizon | Downgraded by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.28
-2.5% | $20.00 ➝ $17.00 | Outperform ➝ Neutral | |
FHTX Foghorn Therapeutics | Target Raised by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.56
+2.6% | $6.00 ➝ $9.00 | Equal Weight ➝ Equal Weight | |
FLS Flowserve | Reiterated by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.14
+7.3% | $60.00 ➝ $60.00 | Buy ➝ Buy | |
FOXA FOX | Target Raised by | Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.32
+2.9% | $44.00 ➝ $45.00 | Buy ➝ Buy | |
GEV GE Vernova | Initiated by | Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $255.48
+1.6% | $300.00 | Buy | |
GNRC Generac | Reiterated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $150.84
+3.1% | $175.00 ➝ $175.00 | Overweight ➝ Overweight | |
HAFC Hanmi Financial | Target Lowered by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.89
-1.6% | $22.00 ➝ $21.00 | Neutral ➝ Neutral | |
HAL Halliburton | Target Lowered by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.97
+0.1% | $47.00 ➝ $46.00 | Buy ➝ Buy | |
Who are Nvidia’s New Silent Partners? (Ad) Nvidia recently became just the third $2 trillion company.
But Nvidia can’t do everything by itself. I call these Nvidia’s “Silent Partners.” |
HD Home Depot | Target Raised by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $400.66
+2.2% | $345.00 ➝ $400.00 | Market Perform ➝ Market Perform | |
HE Hawaiian Electric Industries | Target Lowered by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.90
-9.3% | $16.00 ➝ $9.00 | In-Line ➝ In-Line | |
HRMY Harmony Biosciences | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.82
-1.1% | $52.00 ➝ $52.00 | Buy ➝ Buy | |
HSY Hershey | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $193.34
-0.9% | $204.00 ➝ $202.00 | Equal Weight ➝ Equal Weight | |
HUT Hut 8 | Target Raised by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.50
+8.0% | $15.00 ➝ $16.50 | Buy ➝ Buy | |
IDYA IDEAYA Biosciences | Reiterated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.37
-7.0% | $61.00 ➝ $61.00 | Outperform ➝ Outperform | |
IDYA IDEAYA Biosciences | Target Lowered by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.37
-7.0% | $54.00 ➝ $52.00 | Outperform ➝ Outperform | |
INVH Invitation Homes | Downgraded by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $35.55
-2.6% | $39.00 ➝ $37.00 | Buy ➝ Neutral | |
JAMF Jamf | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.49
-6.5% | $30.00 ➝ $30.00 | Market Outperform ➝ Market Outperform | |
JAMF Jamf | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.49
-6.5% | $25.00 ➝ $25.00 | Buy ➝ Buy | |
JBHT J.B. Hunt Transport Services | Reiterated by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.48
+2.5% | $195.00 ➝ $195.00 | Outperform ➝ Outperform | |
KEY KeyCorp | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.62
-1.1% | $17.00 ➝ $18.00 | Neutral ➝ Neutral | |
KOD Kodiak Sciences | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Caufield
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $2.61
+4.0% | $3.00 ➝ $3.00 | Neutral ➝ Neutral | |
KVUE Kenvue | Downgraded by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.11
+0.4% | $24.00 | Outperform ➝ Sector Perform | |
KVUE Kenvue | Initiated by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.11
+0.4% | $27.00 | Buy | |
LH Laboratory Co. of America | Target Lowered by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $220.60
-1.8% | $250.00 ➝ $240.00 | In-Line ➝ In-Line | |
LI Li Auto | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Chung
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $24.72
+11.4% | $21.60 ➝ $25.50 | Neutral ➝ Neutral | |
LNW Light & Wonder | Target Lowered by | Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Stauff
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $90.71
-19.5% | $92.00 ➝ $90.00 | Neutral ➝ Neutral | |
LOW Lowe's Companies | Upgraded by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $266.04
+1.4% | $230.00 ➝ $305.00 | Market Perform ➝ Outperform | |
LPCN Lipocine | Initiated by | Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.55
+0.2% | $10.00 | Buy | |
LW Lamb Weston | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Moskow
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $64.84
-0.1% | $61.00 ➝ $65.00 | Hold ➝ Hold | |
LWAY Lifeway Foods | Downgraded by | Noble Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Gomes
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $26.57
+23.6% | | Outperform ➝ Market Perform | |
LYFT Lyft | Initiated by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.33
+4.8% | | Market Perform | |
MARA Marathon Digital | Initiated by | Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.41
+2.1% | $22.00 | Outperform | |
MCD McDonald's | Target Raised by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Cho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $300.27
+0.4% | $284.00 ➝ $325.00 | Neutral ➝ Neutral | |
MCK McKesson | Reiterated by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $480.49
-4.9% | $603.00 ➝ $531.00 | Outperform ➝ Neutral | |
MESO Mesoblast | Upgraded by | Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.27
+7.9% | $12.00 | Hold ➝ Buy | |
MNSO MINISO Group | Reiterated by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.40
-2.3% | $27.00 ➝ $15.00 | Overweight ➝ Neutral | |
MOD Modine Manufacturing | Target Raised by | DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $133.69
+5.1% | $140.00 ➝ $155.00 | Buy ➝ Buy | |
MOGO Mogo | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.20
+3.7% | $6.00 ➝ $6.00 | Buy ➝ Buy | |
MOS Mosaic | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.60
+1.0% | $29.00 ➝ $27.00 | Equal Weight ➝ Equal Weight | |
MRNS Marinus Pharmaceuticals | Reiterated by | Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.90
+16.6% | $13.00 ➝ $13.00 | Overweight ➝ Overweight | |
MTB M&T Bank | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.79
-1.6% | $208.00 ➝ $210.00 | Outperform ➝ Outperform | |
NEO NeoGenomics | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.80
| $18.00 ➝ $18.00 | Buy ➝ Buy | |
NHI National Health Investors | Initiated by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $83.82
-1.1% | $92.00 | Buy | |
NSP Insperity | Downgraded by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $86.88
-4.5% | | Outperform ➝ Market Perform | |
NTR Nutrien | Downgraded by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.70
+0.5% | $62.00 ➝ $50.00 | Overweight ➝ Equal Weight | |
OKLO Oklo | Target Lowered by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.31
-0.1% | $11.00 ➝ $10.00 | Neutral ➝ Neutral | |
OKTA Okta | Target Lowered by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.83
-0.5% | $100.00 ➝ $85.00 | Hold ➝ Hold | |
OMF OneMain | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.91
-5.0% | $60.00 ➝ $60.00 | Market Outperform ➝ Market Outperform | |
PB Prosperity Bancshares | Upgraded by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.37
-1.4% | $75.00 ➝ $90.00 | Neutral ➝ Outperform | |
PBH Prestige Consumer Healthcare | Reiterated by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.13
-1.6% | $70.00 ➝ $76.00 | Buy ➝ Hold | |
PCOR Procore Technologies | Initiated by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.15
+3.8% | $73.00 | Outperform | |
PCRX Pacira BioSciences | Target Raised by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.26
-0.1% | $15.00 ➝ $18.00 | Buy ➝ Buy | |
PEG Public Service Enterprise Group | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $87.73
-0.2% | $87.00 ➝ $94.00 | Neutral ➝ Neutral | |
PG Procter & Gamble | Initiated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $173.24
-0.3% | $174.00 | Neutral | |
PINS Pinterest | Initiated by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.66
+3.9% | $45.00 | Outperform | |
PPBI Pacific Premier Bancorp | Target Lowered by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.21
-0.7% | $28.00 ➝ $27.00 | Neutral ➝ Neutral | |
PTGX Protagonist Therapeutics | Initiated by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.58
+0.9% | $65.00 | Buy | |
QUAD Quad/Graphics | Reiterated by | Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Crockett
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $4.71
-2.9% | $7.60 ➝ $7.60 | Buy ➝ Buy | |
Is Starlink Set For The Largest IPO In History? (Ad) He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant.
Then, he did it again with Tesla… which is up more than 19,500% since 2010.
For perspective, that turns $100 invested into almost $20,000! Click here now for the urgent details. |
REGN Regeneron Pharmaceuticals | Reiterated by | Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,045.98
-4.2% | $1,175.00 ➝ $1,077.00 | Outperform ➝ Market Perform | |
REGN Regeneron Pharmaceuticals | Target Lowered by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,045.98
-4.2% | $1,282.00 ➝ $1,252.00 | Outperform ➝ Outperform | |
REGN Regeneron Pharmaceuticals | Reiterated by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,045.98
-4.2% | $1,300.00 ➝ $1,300.00 | Outperform ➝ Outperform | |
REGN Regeneron Pharmaceuticals | Reiterated by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,045.98
-4.2% | $1,200.00 ➝ $1,200.00 | Buy ➝ Buy | |
REPL Replimune Group | Target Raised by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.07
+1.0% | $14.00 ➝ $17.00 | Overweight ➝ Overweight | |
RF Regions Financial | Upgraded by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.92
+0.0% | $23.00 ➝ $28.00 | Neutral ➝ Outperform | |
RGA Reinsurance Group of America | Target Raised by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $219.52
-0.3% | $228.00 ➝ $250.00 | Strong-Buy ➝ Strong-Buy | |
RMD ResMed | Initiated by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $247.15
+0.4% | $280.00 | Outperform | |
RNA Avidity Biosciences | Initiated by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.00
+1.1% | $59.00 | Buy | |
RUN Sunrun | Reiterated by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92
+0.1% | $35.00 ➝ $35.00 | Overweight ➝ Overweight | |
RYAN Ryan Specialty | Upgraded by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.50
+5.3% | $65.00 ➝ $75.00 | Market Perform ➝ Outperform | |
SBUX Starbucks | Downgraded by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.45
-1.1% | $80.00 ➝ $76.00 | Hold ➝ Underperform | |
SHAK Shake Shack | Reiterated by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.06
-2.4% | $105.00 ➝ $102.00 | Underweight ➝ Underweight | |
SIRI Sirius XM | Reiterated by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.10
-5.8% | $23.00 | Underweight | |
SLM SLM | Target Lowered by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.53
-2.4% | $29.00 ➝ $26.00 | Outperform ➝ Outperform | |
SMAR Smartsheet | Reiterated by | DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.46
+6.5% | $55.00 ➝ $56.50 | Buy ➝ Neutral | |
SMAR Smartsheet | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.46
+6.5% | | Buy ➝ Hold | |
SMAR Smartsheet | Reiterated by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.46
+6.5% | $60.00 ➝ $56.50 | Overweight ➝ Neutral | |
SMAR Smartsheet | Reiterated by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.46
+6.5% | $60.00 ➝ $56.50 | Buy ➝ Hold | |
SMAR Smartsheet | Reiterated by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.46
+6.5% | $57.00 | Overweight ➝ Equal Weight | |
SNOW Snowflake | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.68
-0.5% | $155.00 ➝ $125.00 | Neutral ➝ Neutral | |
SOC Sable Offshore | Target Raised by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Chandra
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $24.74
+5.9% | $24.00 ➝ $37.00 | Buy ➝ Buy | |
STZ Constellation Brands | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $252.47
-0.9% | $295.00 ➝ $309.00 | Overweight ➝ Overweight | |
TBLA Taboola.com | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.19
| $5.00 ➝ $5.00 | Buy ➝ Buy | |
TCBI Texas Capital Bancshares | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $70.95
-1.1% | $70.00 ➝ $77.00 | Neutral ➝ Neutral | |
TGI Triumph Group | Downgraded by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.95
-4.4% | $17.00 ➝ $12.00 | Buy ➝ Underperform | |
TMDX TransMedics Group | Initiated by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $156.00
-2.2% | $200.00 | Outperform | |
TRIP Tripadvisor | Target Lowered by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.83
+1.7% | $20.00 ➝ $16.00 | Neutral ➝ Neutral | |
TXRH Texas Roadhouse | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $175.58
+0.2% | $190.00 ➝ $190.00 | Outperform ➝ Outperform | |
UBER Uber Technologies | Initiated by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.44
+3.7% | $90.00 | Strong-Buy | |
UNP Union Pacific | Target Lowered by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $248.95
+2.0% | $273.00 ➝ $270.00 | Buy ➝ Buy | |
V Visa | Reiterated by | Monness Crespi & Hardt
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $272.93
-5.4% | | Neutral | |
VAL Valaris | Initiated by | Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.92
+2.7% | $62.00 | Neutral | |
VLY Valley National Bancorp | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.83
-2.3% | $9.00 ➝ $10.00 | Neutral ➝ Neutral | |
VST Vistra | Target Raised by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.43
+0.7% | $99.00 ➝ $137.00 | Buy ➝ Buy | |
VZ Verizon Communications | Target Raised by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.68
+0.9% | $44.00 ➝ $48.00 | Outperform ➝ Outperform | |
WAL Western Alliance Bancorporation | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.85
-1.7% | $90.00 ➝ $105.00 | Outperform ➝ Outperform | |
WMT Walmart | Upgraded by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.70
+0.5% | $76.00 ➝ $89.00 | Hold ➝ Buy | |
XOM Exxon Mobil | Reiterated by | Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.07
-0.2% | $119.00 ➝ $120.00 | Buy ➝ Neutral | |
ZVRA Zevra Therapeutics | Target Raised by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.27
+9.1% | $19.00 ➝ $21.00 | Buy ➝ Buy | |
ZVRA Zevra Therapeutics | Initiated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.27
+9.1% | $17.00 | Outperform | |
ZVRA Zevra Therapeutics | Target Raised by | Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.27
+9.1% | $18.00 ➝ $25.00 | Buy ➝ Buy | |
